A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
Condition(s):Bipolar DepressionLast Updated:January 29, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Bipolar DepressionLast Updated:January 29, 2024Recruiting
Condition(s):Bipolar DisorderLast Updated:February 7, 2024Recruiting
Condition(s):Bipolar DisorderLast Updated:December 5, 2023Recruiting
Condition(s):Postpartum DepressionLast Updated:October 4, 2023Recruiting
Condition(s):Bipolar DisorderLast Updated:May 2, 2022Not yet recruiting
Condition(s):Bipolar DisorderLast Updated:January 12, 2024Completed
Condition(s):Bipolar Depression; Bipolar I DisorderLast Updated:January 18, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.